Dingzhong Peng and Jiong Lu contributed equally to this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The objective of our research was to investigate the value of the lymphocyte to monocyte ratio (LMR) and its dynamic changes (LMRc) in predicting tumor resectability and early recurrence of radiologically resectable type IV hilar cholangiocarcinoma (HC).
A total of 411 patients with radiologically resectable type IV HC were included. Data on their clinicopathologic characteristics, perioperative features, and survival outcomes were analyzed. Receiver operating characteristic (ROC) analysis was conducted to assess the ability of preoperative LMR (pre-LMR) to predict tumor resectability, and the ability of postoperative LMR (post-LMR) to discriminate between early and late recurrence. Survival curves were calculated using the Kaplan–Meier estimate. Univariate and multivariate logistic regression models were used to identify factors associated with resectability and early recurrence.
Of 411 patients with potentially curative type IV HC, 254 underwent curative surgery. The optimal cutoff value of pre-LMR as an indicator of resectability was 3.67, and the optimal cutoff value of post-LMR for detecting early recurrence was 4.10. In the multivariate logistic regression model, CA19-9 > 200 U/mL, pre-LMR ≤ 3.67, and tumor size > 3 cm were found to be independent risk factors for poor resectability. Moreover, multivariate analysis showed that LMRc, resection margin, AJCC N stage, and lymphovascular invasion were independent risk factors associated with early recurrence.
Pre-LMR is a valuable indicator of resectability and LMRc is a valuable predictor of early recurrence in patients with curative type IV HC.
Baton O, Azoulay D, Adam DV, Castaing D. Major hepatectomy for hilar cholangiocarcinoma type 3 and 4: prognostic factors and longterm outcomes. J Am Coll Surg. 2007;204(2):250–60. doi: https://doi.org/10.1016/j.jamcollsurg.2006.10.028. CrossRefPubMed
Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz J et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Annals of Surgery. 2001;234(4):507–17. doi: https://doi.org/10.1097/00000658-200110000-00010. CrossRefPubMedPubMedCentral
Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surgery and Nutrition. 2014;3(1):18–34. doi: https://doi.org/10.3978/j.issn.2304-3881.2014.02.05. CrossRefPubMedPubMedCentral
Zhang W, Liu K, Ye B, Liang W, Ren Y. Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer. Cancer Medicine. 2017. doi: https://doi.org/10.1002/cam4.1270.
McNamara MG, Templeton AJ, Maganti M, Walter T, Horgan AM, McKeever L et al. Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract cancer. European Journal of Cancer. 2014;50(9):1581–9. doi: https://doi.org/10.1016/j.ejca.2014.02.015. CrossRefPubMed
Grenader T, Nash S, Plotkin Y, Furuse J, Mizuno N, Okusaka T et al. Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2015;26(9):1910–6. doi: https://doi.org/10.1093/annonc/mdv253. CrossRef
Chan JCY, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A et al. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Annals of Surgery. 2017;265(3):539–46. doi: https://doi.org/10.1097/Sla.0000000000001743. CrossRefPubMed
Ozawa T, Ishihara S, Kawai K, Kazama S, Yamaguchi H, Sunami E et al. Impact of a lymphocyte to monocyte ratio in stage IV colorectal cancer. J Surg Res. 2015;199(2):386–92. doi: https://doi.org/10.1016/j.jss.2015.06.014. CrossRefPubMed
Dumitrascu T, Chirita D, Ionescu M, Popescu I. Resection for Hilar Cholangiocarcinoma: Analysis of Prognostic Factors and the Impact of Systemic Inflammation on Long-term Outcome. Journal of Gastrointestinal Surgery. 2013;17(5):913–24. doi: https://doi.org/10.1007/s11605-013-2144-2. CrossRefPubMed
Dindo D, Demartines N, Clavien PA. Classification of surgical complications—A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery. 2004;240(2):205–13. doi: https://doi.org/10.1097/01.sla.0000133083.54934.ae. CrossRefPubMedPubMedCentral
Zhang XF, Beal EW, Chakedis J, Chen Q, Lv Y, Ethun CG et al. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium. World Journal of Surgery. 2018;42(9):2919–29. doi: https://doi.org/10.1007/s00268-018-4530-0. CrossRefPubMed
Groot Koerkamp B, Wiggers JK, Allen PJ, Besselink MG, Blumgart LH, Busch OR et al. Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. J Am Coll Surg. 2015;221(6):1041–9. doi: https://doi.org/10.1016/j.jamcollsurg.2015.09.005. CrossRefPubMedPubMedCentral
Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990;159(1):91–7; discussion 7-8. CrossRef
Ji GW, Zhu FP, Wang K, Jiao CY, Shao ZC, Li XC. Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 2017;21(4):666–75. doi: https://doi.org/10.1007/s11605-017-3377-2. CrossRef
Lin JP, Lin JX, Cao LL, Zheng CH, Li P, Xie JW et al. Preoperative lymphocyte-to-monocyte ratio as a strong predictor of survival and recurrence for gastric cancer after radical-intent surgery. Oncotarget. 2017;8(45):79234–47. doi: https://doi.org/10.18632/oncotarget.17058. CrossRefPubMedPubMedCentral
Hu RJ, Ma JY, Hu G. Lymphocyte-to-monocyte ratio in pancreatic cancer: Prognostic significance and meta-analysis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 2018;481:142–6. doi: https://doi.org/10.1016/j.cca.2018.03.008. CrossRefPubMed
Seyama Y, Kubota K, Sano K, Noie T, Takayama T, Kosuge T et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Annals of Surgery. 2003;238(1):73–83. doi: https://doi.org/10.1097/01.SLA.0000074960.55004.72. CrossRefPubMedPubMedCentral
Chen T, Zhang MG, Xu HX, Wang WQ, Liu L, Yu XJ. Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma. Medicine. 2015;94(19):e751. doi: https://doi.org/10.1097/MD.0000000000000751. CrossRefPubMedPubMedCentral
Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, Khor CJL, Ponnudurai R, Moon JH et al. AsiaPacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. Journal of Gastroenterology and Hepatology. 2013;28(4):593–607. doi: https://doi.org/10.1111/jgh.12128. CrossRefPubMed
Murad SD, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM et al. Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers. Gastroenterology. 2012;143(1):88-U610. doi: https://doi.org/10.1053/j.gastro.2012.04.008. CrossRef
Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GAM et al. Early and late recurrence after liver resection for hepatocellular carcinoma—Prognostic and therapeutic implications. Annals of Surgery. 2006;243(2):229–35. doi: https://doi.org/10.1097/01.sla.0000197706.21803.a1. CrossRefPubMedPubMedCentral
Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R et al. Changes in blood lymphocyte populations after multiple trauma: Association with posttraumatic complications. Crit Care Med. 1999;27(4):733–40. doi: https://doi.org/10.1097/00003246-199904000-00026. CrossRefPubMed
Iwase R, Shiba H, Haruki K, Fujiwara Y, Furukawa K, Futagawa Y et al. Post-operative lymphocyte count may predict the outcome of radical resection for gallbladder carcinoma. Anticancer Research. 2013;33(8):3439–44. PubMed
Zhang XF, Squires MH, 3rd, Bagante F, Ethun CG, Salem A, Weber SM et al. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma. Annals of Surgical Oncology. 2018;25(5):1140–9. doi: https://doi.org/10.1245/s10434-018-6382-0. CrossRefPubMed
- Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma
- Springer US
Journal of Gastrointestinal Surgery
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
Neu im Fachgebiet Chirurgie
Mail Icon II